Amgen: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Other Events, Financial Statements And Exhibits
January 30, 2023
U.S. Securities and Exchange Commission
|Show full article|
This functionality is available for registred users only
Company — Amgen
Full nameAmgen, Inc.
IndustryPharmaceutical Preparation and Biotechnology